A*STAR Bioprocessing Technology Institute (A*STAR BTI)

Efficient production of glycoprotein drugs to treat anemia and other disorders comes a step closer via genetic engineering

An evaluation study shows that more efficient cell-sorting methods are needed to make stem cell-derived tissues sufficiently safe for transplantation

An antibody that selectively kills off undifferentiated stem cells may improve their clinical usefulness

Embryonic stem cells keep their developmental options open with help from two recently identified genes